HK1130264A1 - Compositions and their uses directed to diacylglycerol acyltransferase 1 - Google Patents

Compositions and their uses directed to diacylglycerol acyltransferase 1

Info

Publication number
HK1130264A1
HK1130264A1 HK09110220.2A HK09110220A HK1130264A1 HK 1130264 A1 HK1130264 A1 HK 1130264A1 HK 09110220 A HK09110220 A HK 09110220A HK 1130264 A1 HK1130264 A1 HK 1130264A1
Authority
HK
Hong Kong
Prior art keywords
compositions
diacylglycerol acyltransferase
uses directed
directed
acyltransferase
Prior art date
Application number
HK09110220.2A
Other languages
English (en)
Inventor
Xing-Xian Yu
Sanjay Bhanot
Brett P Monia
Original Assignee
Isis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Pharmaceuticals Inc filed Critical Isis Pharmaceuticals Inc
Publication of HK1130264A1 publication Critical patent/HK1130264A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y203/00—Acyltransferases (2.3)
    • C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12Y203/0102—Diacylglycerol O-acyltransferase (2.3.1.20)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK09110220.2A 2006-08-04 2009-11-04 Compositions and their uses directed to diacylglycerol acyltransferase 1 HK1130264A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82151106P 2006-08-04 2006-08-04
PCT/US2007/075297 WO2008019351A2 (fr) 2006-08-04 2007-08-06 Compositions et leurs utilisations dirigées sur la diacylglycérol acyltransférase 1

Publications (1)

Publication Number Publication Date
HK1130264A1 true HK1130264A1 (en) 2009-12-24

Family

ID=39033610

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09110220.2A HK1130264A1 (en) 2006-08-04 2009-11-04 Compositions and their uses directed to diacylglycerol acyltransferase 1

Country Status (5)

Country Link
US (2) US8003620B2 (fr)
EP (1) EP2057177B1 (fr)
ES (1) ES2397661T3 (fr)
HK (1) HK1130264A1 (fr)
WO (1) WO2008019351A2 (fr)

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6867039B2 (en) 2001-05-25 2005-03-15 Isis Pharmaceuticals, Inc. Antisense modulation of dual specific phosphatase 5 expression
US6582908B2 (en) 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
US5801154A (en) 1993-10-18 1998-09-01 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of multidrug resistance-associated protein
US5708160A (en) 1995-04-26 1998-01-13 The National Research Council HSP-60 genomic locus and primers for species identification
WO2000078961A1 (fr) 1999-06-23 2000-12-28 Genentech, Inc. Polypeptides secretes et transmembranaires et acides nucleiques codant pour ces polypeptides
US20030228597A1 (en) 1998-04-13 2003-12-11 Cowsert Lex M. Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulation
US20030167483A1 (en) 1998-06-24 2003-09-04 Farese Robert V. Diacylglycerol O-acyltransferase
US6344548B1 (en) 1998-06-24 2002-02-05 The Regents Of The University Of California Diacylglycerol o-acyltransferase
ATE406448T1 (de) 1998-06-24 2008-09-15 David Gladstone Inst Diacylglycerin o-acyltransferase
US20030100480A1 (en) 1998-06-24 2003-05-29 Smith Steven J. Methods and compositions for modulating sebaceous glands
US20030154504A1 (en) * 1998-06-24 2003-08-14 Farese Robert V. Methods and compositions for modulating carbohydrate metabolism
US7135617B2 (en) 1998-07-02 2006-11-14 Calgene Llc Diacylglycerol acyl transferase proteins
ATE442435T1 (de) 1998-07-02 2009-09-15 Calgene Llc Diacylglyzerin-acyltransferase proteine
US6100077A (en) 1998-10-01 2000-08-08 The Trustees Of Columbia University In The City Of New York Isolation of a gene encoding diacylglycerol acyltransferase
US5998148A (en) 1999-04-08 1999-12-07 Isis Pharmaceuticals Inc. Antisense modulation of microtubule-associated protein 4 expression
AU6802801A (en) 2000-03-01 2001-09-24 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2403946A1 (fr) 2000-04-05 2001-10-18 Incyte Genomics, Inc. Genes exprimes lors de la differenciation de cellules spumeuses
US6444427B1 (en) 2000-07-11 2002-09-03 The Regents Of The University Of California Polymorphisms in a diacylglycerol acyltransferase gene, and methods of use thereof
WO2002008260A2 (fr) 2000-07-26 2002-01-31 Stanford University Proteine bstp-ecg1 et reactifs associes et procedes d'utilisation de ceux-ci
DE01992795T1 (de) 2000-10-31 2004-12-16 Michel Alphonse Julien Georges Marker-unterstützte auswahl von rindvieh für verbesserte milchproduktion unter verwendung des diacylglycerin-acyltransferase-gens dgat1
MXPA01012317A (es) 2000-12-28 2002-07-22 Warner Lambert Co Prueba de aciltransferasa del diacilglicerol (dgat).
US6440738B1 (en) 2001-02-08 2002-08-27 Isis Pharmaceuticals, Inc. Antisense modulation of casein kinase 2-beta expression
US20020119138A1 (en) 2001-02-26 2002-08-29 Sylvaine Cases Diacylglycerol o-acyltransferase 2alpha (DGAT2alpha)
US7045326B2 (en) 2001-02-23 2006-05-16 The Regents Of The University Of California Mono- and diacylglycerol acyltransferases and methods of use thereof
US20030161831A1 (en) 2001-02-23 2003-08-28 Sylvaine Cases Mono-and diacylglycerol acyltransferases and methods of use thereof
JP2002284741A (ja) 2001-03-23 2002-10-03 Kitasato Inst:The ローズリピン誘導体
US6835556B2 (en) 2001-04-12 2004-12-28 Pharmacia Ab Protein cluster V
WO2002086085A2 (fr) 2001-04-24 2002-10-31 Bayer Corporation Anticorps timp-1 humains
US20040234986A1 (en) 2001-07-06 2004-11-25 Hans-Rudolf Fries Method of testing a mammal for its predisposition for fat content of milk and/ or its predisposition for meat marbling
EP1308459A3 (fr) 2001-11-05 2003-07-09 Research Association for Biotechnology Séquences d'ADN complementaires pleine longueur
AU2002360531A1 (en) 2001-12-10 2003-06-23 Millennium Pharmaceuticals, Inc. Methods and compositions to treat cardiovascular disease using 1419, 58765 and 2201
WO2003052090A1 (fr) 2001-12-17 2003-06-26 E. I. Du Pont De Nemours And Company Phospholipide : diacylglycerol acyltransferases
US20030170691A1 (en) 2001-12-19 2003-09-11 Millennium Pharmaceuticals, Inc. Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor
US6847366B2 (en) * 2002-03-01 2005-01-25 Hewlett-Packard Development Company, L.P. System and method utilizing multiple processes to render graphical data
EP1496838B1 (fr) 2002-03-12 2010-11-03 Merck Sharp & Dohme Corp. Amides substitues
US7105526B2 (en) 2002-06-28 2006-09-12 Banyu Pharmaceuticals Co., Ltd. Benzimidazole derivatives
BR0313536A (pt) 2002-07-31 2005-06-14 Monsanto Technology Llc Sequencias de ácido nucléico de diacilglicerol acetiltransferase e produtos associados
JP2006507841A (ja) 2002-11-14 2006-03-09 ダーマコン， インコーポレイテッド 機能的ｓｉＲＮＡおよび超機能的ｓｉＲＮＡ
US20040122033A1 (en) 2002-12-10 2004-06-24 Nargund Ravi P. Combination therapy for the treatment of obesity
US20040185559A1 (en) * 2003-03-21 2004-09-23 Isis Pharmaceuticals Inc. Modulation of diacylglycerol acyltransferase 1 expression
US7795283B2 (en) * 2004-12-14 2010-09-14 Astrazeneca Ab Oxadiazole derivative as DGAT inhibitors

Also Published As

Publication number Publication date
US20090054359A1 (en) 2009-02-26
WO2008019351A2 (fr) 2008-02-14
EP2057177A4 (fr) 2009-10-28
US8003620B2 (en) 2011-08-23
EP2057177A2 (fr) 2009-05-13
WO2008019351A3 (fr) 2008-10-16
EP2057177B1 (fr) 2012-11-21
US20120029050A1 (en) 2012-02-02
WO2008019351A8 (fr) 2011-12-29
US8455456B2 (en) 2013-06-04
ES2397661T3 (es) 2013-03-08

Similar Documents

Publication Publication Date Title
ZA200903692B (en) Inhinitors of diacylglycerol o-acylotransferase type 1 enzyme
HK1141449A1 (en) Compositions and their uses directed to huntingtin
IL228131A (en) Fibrous materials and preparations
AP2008004713A0 (en) Improvements relating to anti-parasetic compositions
IL196848A0 (en) Antibodies directed to ??v??6 and uses thereof
GB0602325D0 (en) Virucidal compositions and uses
EP2023936A4 (fr) Compositions et leurs utilisations associées au récepteur ptpr alpha
EP2120567A4 (fr) Promédicaments de 1,3-dioxanes substitués et leurs utilisations
GB0611743D0 (en) Skincare composition
GB0622399D0 (en) Novel compositions and uses thereof
IL193469A0 (en) Novel lipases and uses thereof
GB0702871D0 (en) Improved compositions and combinations 1
EP1924294A4 (fr) Compositions et leurs utilisations permettant de moduler l'expression de ptpru
EP1998753A4 (fr) Compositions pour depot important et leurs utilisations
KZ19064A (en) Windmill-electric generating plant Buktukov 4
GB0615609D0 (en) Uses and compositions comprising miRNAs
IL202496A0 (en) Compounds and uses thereof 849
ZA200902338B (en) Uses of fischer-tropsch fuel compositions
GB0715428D0 (en) Compositions and uses thereof
GB0622400D0 (en) Novel compositions and uses thereof
GB0701170D0 (en) Compositions and uses thereof
EP1871351A4 (fr) Compositions et leurs utilisations par rapport aux aceytl-coa carboxylases
EP2010141A4 (fr) Compositions à fort dépôt et leurs utilisations
HK1130264A1 (en) Compositions and their uses directed to diacylglycerol acyltransferase 1
GB0701171D0 (en) Compositions and uses thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160806